Cingulate Therapeutics



Cingulate® is a biopharmaceutical company utilizing its innovative Precision Timed Release™ (PTR) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products.

Shane J. Schaffer
Chairman & CEO
Shane J. Schaffer
Raul R. Silva
Chief Science Officer
Matthew Brams
Chief Medical Officer
Craig S. Gilgallon
General Counsel

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.